Here's Why Keryx Biopharmaceuticals Dropped 19.6% in August

The pharma company announced second-quarter 2018 earnings.
Multiple users said they had problems after the DNA-testing firm filed for bankruptcy protection. from BBC News https://ift.tt/1IUshML
0 comments:
Post a Comment